Banner Alzheimer's Institute (BAI) is home to international leaders specializing in brain imaging, detection of presymptomatic Alzheimer's disease and the creation of a new standard of care for patients and families.
Our leadership believes that now is the time to launch the era of Alzheimer's prevention research and achieve our mission to end Alzheimer's without losing another generation.
Meet our visionary leaders:
Eric M. Reiman, MD
Executive Director, Banner Alzheimer's Institute & CEO, Banner Research
Professor of Psychiatry, University of Arizona
University Professor of Neuroscience, Arizona State University
Clinical Director of Neurogenomics, Translational Genomics Research Institute
Director, Arizona Alzheimer's ConsortiumDr. Eric Reiman is chief executive officer of Banner Research, executive director of Banner Alzheimer's Institute, clinical director of the Neurogenomics Division at the Translational Genomics Research Institute (TGen), professor of psychiatry at the University of Arizona, and director of the Arizona Alzheimer's Consortium.
His research interests include brain imaging, genomics and their application to the study of normal and abnormal human behaviors; the early detection, tracking and study of Alzheimer's disease; and the accelerated evaluation of presymptomatic Alzheimer's disease treatments.
Dr. Reiman is internationally recognized for his contributions to the fields of brain imaging, the behavioral neurosciences and the presymptomatic study of Alzheimer's disease. He is the author of more than 200 research publications and serves as principal investigator for research grants from the National Institutes of Health and other leading funders.
Dr. Reiman and his colleagues have developed the international Alzheimer's Prevention Initiative to find effective treatments to prevent Alzheimer's disease as quickly as possible.
Pierre N. Tariot,
Director, Banner Alzheimer's Institute
Dr. Pierre Tariot, director of Banner Alzheimer's Institute, is board-certified in internal medicine and geriatric psychiatry.
He received intensive training in developing new treatments for Alzheimer's disease at the National Institutes of Health. He went on to spend 20 years as a professor at the University of Rochester Medical Center in New York, where he directed a program dedicated to the care and study of those with Alzheimer's. In 2006, he joined Dr. Eric Reiman to launch Banner Alzheimer's Institute and serve as a research professor at the University of Arizona College of Medicine.
He is a fellow of the Gerontological Society of America, distinguished fellow of the American Psychiatric Association and member of the American College of Neuropsychopharmacology. He also is a past chair of the Behavioral Pathology Committee of the National Institute on Aging's Consortium to Establish a Registry for Alzheimer's Disease.
Dr. Tariot has investigated and lectured extensively on multiple aspects of diagnosis and therapy for dementia and Alzheimer's as well as recognition and management of behavioral disturbances in dementia. He has devoted his career to helping patients and families cope with the effects of dementia and is a recognized leader in the development of new Alzheimer's treatments. He has published hundreds of scientific articles, is a widely sought-after speaker and consultant, and has won numerous awards for his service and research.
William Burke, MD
Stead Family Memory Center
Dr. William Burke is the Director of the Stead Family Memory
Center and a board-certified physician in geriatric psychiatry. Dr.
Burke received his medical degree from the University of Nebraska
Medical Center in Omaha, NE where he also completed an internship
in Internal Medicine. He performed his residency in Psychiatry at
Barnes Hospital and Washington University Medical School in St.
Louis, MO. He received additional post-graduate training at the
Alzheimer Disease Research Center at Washington University while
also studying psychiatric epidemiology.
Dr. Burke spent more than 25 years at the University of Nebraska Medical Center where he was the Anna O. Stake Professor of Psychiatry, the Vice-Chair for Research and Director of the Psychopharmacology Research Center at UNMC. His research interests have focused on evaluation of potential new treatments for Alzheimer disease, delirium and depression with a particular interest in disease prevention. He has published widely including scientific articles, book chapters and abstracts. Dr. Burke has been repeatedly cited as a Castle Connolly/U.S. News "Top Doctor" and in "Best Doctors in America."